About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Screening: Journal of the International Society of Neonatal Screening
›
top-articles
Screening: Journal of the International Society of Neonatal Screening
0.3
(top 100%)
impact factor
115
(top 100%)
papers
1.0K
(top 50%)
citations
15
(top 50%)
h
-index
0.3
(top 100%)
impact factor
155
all documents
1.0K
doc citations
29
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
Screening: Journal of the International Society of Neonatal Screening
1993
147
2
The origin of newborn screening
Screening: Journal of the International Society of Neonatal Screening
1992
88
3
Newborn screening for cystic fibrosis: Its evolution and a review of the current situation
Screening: Journal of the International Society of Neonatal Screening
1993
64
4
U.S. newborn screening system guidelines: Statement of the council of regional networks for genetic services
Screening: Journal of the International Society of Neonatal Screening
1992
56
5
Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational age
Screening: Journal of the International Society of Neonatal Screening
1994
47
6
Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: An anonymous pilot study in Denmark
Screening: Journal of the International Society of Neonatal Screening
1993
36
7
Nationwide survey of neonatal mass-screening for congenital adrenal hyperplasia in Japan
Screening: Journal of the International Society of Neonatal Screening
1994
31
8
Quality control for bacterial inhibition assays: DNA fingerprinting of microorganisms by rep-PCR
Screening: Journal of the International Society of Neonatal Screening
1992
27
9
A method of PKU screening using phenylalanine dehydrogenase and microplate system
Screening: Journal of the International Society of Neonatal Screening
1992
26
10
Microassay system for newborn screening for phenylketonuria, maple syrup urine disease, homocystinuria, histidinemia and galactosemia with use of a fluorometric microplate reader
Screening: Journal of the International Society of Neonatal Screening
1992
24
11
Validity of screening early collected newborn specimens for phenylketonuria using a fluorometric method
Screening: Journal of the International Society of Neonatal Screening
1994
21
12
Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus
Screening: Journal of the International Society of Neonatal Screening
1993
19
13
Influence of iodine excess due to iodine-containing antiseptics on neonatal screening for congenital hypothyroidism in Hokkaido prefecture, Japan
Screening: Journal of the International Society of Neonatal Screening
1994
19
14
Incidence of congenital malformations in congenital hypothyroidism
Screening: Journal of the International Society of Neonatal Screening
1994
17
15
Neonatal mass screening for biliary atresia
Screening: Journal of the International Society of Neonatal Screening
1993
16
16
Neonatal screening for Duchenne/Becker muscular dystrophy; Reconsideration based on molecular diagnosis and potential therapeutics
Screening: Journal of the International Society of Neonatal Screening
1992
15
17
Screening of half a million Swedish newborn infants for congenital adrenal hyperplasia
Screening: Journal of the International Society of Neonatal Screening
1992
14
18
Effect of specimen collection method on newborn screening for PKU
Screening: Journal of the International Society of Neonatal Screening
1994
14
19
Results of pilot screening activities in the French neonatal screening program — cystic fibrosis, congenital adrenal hyperplasia and sickle cell disease
Screening: Journal of the International Society of Neonatal Screening
1993
13
20
Evaluation of an enzymatic, colorimetric method for the neonatal screening of phenylketonuria
Screening: Journal of the International Society of Neonatal Screening
1993
13
21
A new method to detect homocysteine in dried blood spots using thin layer chromatography
Screening: Journal of the International Society of Neonatal Screening
1995
13
22
Delayed increase in blood phenylalanine concentration in phenylketonuric children initially classified as mild hyperphenylalaninemia
Screening: Journal of the International Society of Neonatal Screening
1995
13
23
Screening tests for adenylosuccinase deficiency
Screening: Journal of the International Society of Neonatal Screening
1995
13
24
Neonatal screening in France
Screening: Journal of the International Society of Neonatal Screening
1993
12
25
Early discharge from the newborn nursery
Screening: Journal of the International Society of Neonatal Screening
1994
12
26
Phenylketonuria screening using the Quantase phenylalanine kit in combination with a microfilter system and the dye Tartrazine
Screening: Journal of the International Society of Neonatal Screening
1995
12
27
Cognitive function in early treated biotinidase deficiency: Follow-up of children detected by newborn screening
Screening: Journal of the International Society of Neonatal Screening
1995
11
28
Comparison of the effects of season and prematurity on the enzymatic newborn screening tests for galactosemia and biotinidase deficiency
Screening: Journal of the International Society of Neonatal Screening
1993
10
29
Use of the Guthrie bacterial inhibition assay to monitor blood phenylalanine for dietary treatment of phenylketonuria
Screening: Journal of the International Society of Neonatal Screening
1996
10
30
Newborn screening for biotinidase deficiency: pilot study and follow-up of identified cases
Screening: Journal of the International Society of Neonatal Screening
1992
9
31
Erythrocyte uridine diphosphate galactose-4-epimerase deficiency identified by newborn screening for galactosemia in the United States
Screening: Journal of the International Society of Neonatal Screening
1993
9
32
Results of screening for phenylketonuria using a lower cutoff value in early collected specimens
Screening: Journal of the International Society of Neonatal Screening
1995
9
33
Phenylketonuria screening in Moscow using a microplate fluorometric method
Screening: Journal of the International Society of Neonatal Screening
1992
8
34
Neuropsychological development during the first two years in children with congenital hypothyroidism screened at birth: the Cuban experience
Screening: Journal of the International Society of Neonatal Screening
1992
8
35
A quantitative fluorometric micromethod used for the neonatal screening of biotinidase deficiency in Finland
Screening: Journal of the International Society of Neonatal Screening
1992
7
36
Comparison of HPLC and ELISA methods in neuroblastoma screening
Screening: Journal of the International Society of Neonatal Screening
1993
7
37
An audit of infants ‘unscreened’ by the neonatal screening system in Scotland during 1991
Screening: Journal of the International Society of Neonatal Screening
1995
7
38
Neonatal screening for cystic fibrosis using blood trypsin with complementary meconium lactase: an advisable strategy for the population of southern Europe
Screening: Journal of the International Society of Neonatal Screening
1995
7
39
Neonatal screening for congenital hypothyroidism in Saudi Arabia: results of screening the first 1 million newborns
Screening: Journal of the International Society of Neonatal Screening
1996
7
40
Screening for neuroblastoma in infants: more questions than answers
Screening: Journal of the International Society of Neonatal Screening
1992
6
41
What do immunoreactive trypsin assays measure?
Screening: Journal of the International Society of Neonatal Screening
1994
6
42
Neonatal PKU screening in Turkey: 7 years experience in a developing country
Screening: Journal of the International Society of Neonatal Screening
1995
6
43
Fragile X syndrome: examination of issues pertaining to population-based screening
Screening: Journal of the International Society of Neonatal Screening
1996
6
44
Mass screening to identify babies with dyslipoproteinemia by measuring the levels of apoA-I, apoB and the ratio of apoB to apoA-I on dried blood spots
Screening: Journal of the International Society of Neonatal Screening
1992
5
45
Cystic fibrosis neonatal screening — A continuing dilemma, especially in North America
Screening: Journal of the International Society of Neonatal Screening
1993
5
46
Early newborn specimen: Survey of practices among newborn screening programs in the United States
Screening: Journal of the International Society of Neonatal Screening
1995
5
47
The addition of dopamine determination to the measurement of acidic catecholamine metabolites in urine screening for neuroblastoma
Screening: Journal of the International Society of Neonatal Screening
1995
5
48
Later manifestations of congenital hypothyroidism predicted by slightly elevated thyrotropin levels in neonatal screening
Screening: Journal of the International Society of Neonatal Screening
1995
5
49
Screening infants for neuroblastoma in Japan
Screening: Journal of the International Society of Neonatal Screening
1992
4
50
Twenty-five years experience with newborn screening for phenylketonuria (PKU) in Poland
Screening: Journal of the International Society of Neonatal Screening
1993
4
site/software ©
exaly
; All materials licenced under
CC by-SA
.